Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 1 trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 3 Country / region: Italy Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20032
20051
20061
20071
20083
20092
20104
20123
20143
20153
20163
20172
20192
20212
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Recruiting4
Terminated2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S12
Eli Lilly and Company8
Andromeda Biotech Ltd.2
GlaxoSmithKline2
IRCCS San Raffaele2
Lexicon Pharmaceuticals2
Sanofi2
AstraZeneca1
Bayer1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 141
Diabetes Mellitus15
Diabetes Mellitus, Type 21
Hypoglycemia1
Obesity1
Overweight1
Renal Insufficiency, Chronic1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.